Earlier today, the Institute for Clinical and Economic Review (ICER) shared its Final Evidence Report on Midomafetamine-Assisted Psychotherapy for Post-Traumatic Stress Disorder (PTSD).1 Lykos...| Lykos Therapeutics - News Release Archive
Dear Colleagues, As you know, Lykos is entering the final stages of a multi-year effort to study and apply for approval from the U.S. Food and Drug Administration (FDA) for midomafetamine (MDMA)...| Lykos Therapeutics - News Release Archive
U.S. Food and Drug Administration requests additional Phase 3 study Issues raised in CRL echo those discussed in FDA Advisory Committee hearing The Company intends to pursue all available...| Lykos Therapeutics - News Release Archive